CS Diagnostics Corp. CSDX
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -12.20K | -- | -- | -- |
| Total Other Revenue | 204.00K | 110.90K | -- | -- | -- |
| Total Revenue | 204.00K | 98.70K | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 204.00K | 98.70K | -- | -- | -- |
| SG&A Expenses | 132.80K | 79.30K | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 132.80K | 79.30K | -- | -- | -- |
| Operating Income | 71.20K | 19.40K | -- | -- | -- |
| Income Before Tax | 71.20K | 19.40K | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 0.07 | 0.02 | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 71.20K | 19.40K | -- | -- | -- |
| EBIT | 71.20K | 19.40K | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | -- | -- | -- |
| Normalized Basic EPS | 0.00 | 0.00 | -- | -- | -- |
| EPS Diluted | 0.00 | 0.00 | -- | -- | -- |
| Normalized Diluted EPS | 0.00 | 0.00 | -- | -- | -- |
| Average Basic Shares Outstanding | 999.88M | 591.49M | -- | -- | -- |
| Average Diluted Shares Outstanding | 999.88M | 591.49M | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |